Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
101 studies found for:    Open Studies | "Conjunctivitis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Conjunctivitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Condition: Viral Conjunctivitis
Interventions: Drug: dexamethasone 0.1%/povidone-iodine 0.4%;   Drug: Artificial Tears
2 Recruiting Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: hydrocortisone ophthalmic ointment 0.5%;   Drug: placebo
3 Unknown  Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Conditions: Conjunctivitis;   Adenovirus.
Interventions: Drug: Ophthalmic gel (placebo);   Drug: Ganciclovir
4 Recruiting Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients
Condition: Ligneous Conjunctivitis
Intervention: Biological: Human Plasminogen
5 Unknown  Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
Conditions: Bacterial Conjunctivitis;   Acute
Interventions: Drug: MAXINOM®;   Drug: Maxitrol®
6 Unknown  Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
Condition: Acute Bacterial Conjunctivitis
Interventions: Drug: Tobracort;   Drug: Tobradex
7 Recruiting Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Auriclosene Ophthalmic Solution;   Drug: Vehicle Ophthalmic Solution
8 Unknown  Moxifloxacin vs. Polytrim for Conjunctivitis
Condition: Conjunctivitis
Interventions: Drug: moxifloxacin;   Drug: polytrim
9 Recruiting Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in Environmental Exposure Chamber
Condition: Allergic Rhino-Conjunctivitis
Intervention: Drug: AllerT
10 Recruiting ADenoVirus Initiative Study in Epidemiology in France
Condition: Viral Conjunctivitis
Intervention:
11 Recruiting ADenoVirus Initiative Study in Epidemiology in Spain
Condition: Viral Conjunctivitis
Intervention:
12 Recruiting ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
13 Not yet recruiting ADenoVirus Initiative Study in Epidemiology in UK
Condition: Viral Conjunctivitis
Intervention:
14 Recruiting AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Interventions: Drug: AGN-229666;   Drug: Vehicle to AGN-229666;   Drug: Olopatadine
15 Recruiting Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis;   Atopic Dermatitis
Interventions: Biological: XmAb7195;   Biological: Placebo
16 Unknown  A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Condition: Allergic Conjunctivitis
Intervention:
17 Recruiting A Multi-Center Study Evaluating the Safety of AC-170 0.24%
Condition: Atopc Disease (Including Allergic Conjunctivitis)
Interventions: Drug: Drug: AC-170 0.24%;   Drug: AC-170 0%
18 Unknown  Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Conditions: Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions: Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)
19 Recruiting A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
Conditions: Keratoconjunctivitis Due to Adenovirus;   Viral Shedding
Interventions: Drug: Zirgan;   Drug: genteal gel
20 Not yet recruiting Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
Condition: Allergy
Intervention: Drug: Oralair

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years